

![]() |
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer |
|
Authors | ![]() | |
Published in | Clinical Cancer Research. 2016, vol. 22, no. 12, p. 3037-47 | |
Abstract | SMAD4 loss is associated with the development of metastases and poor prognosis. We evaluated expression of SMAD4 protein and its association with tumor characteristics, including biomarkers and outcome in terms of relapse-free survival and overall survival. | |
Identifiers | PMID: 26861460 | |
Full text | ||
Structures | ||
Research group | Lymphomes MALT et réplication virale (807) | |
Citation (ISO format) | YAN, Pu et al. Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer. In: Clinical Cancer Research, 2016, vol. 22, n° 12, p. 3037-47. doi: 10.1158/1078-0432.CCR-15-0939 https://archive-ouverte.unige.ch/unige:84838 |